Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 429,860 | 538,075 | 468,607 | 612,710 | 715,554 |
| Marketable Securities | 40,214 | 90,659 | 306,269 | 313,723 | 300,921 |
| Receivables | 38,926 | 37,097 | 27,000 | 21,704 | 21,871 |
| Inventories | 183,099 | 161,922 | 137,677 | 104,724 | 107,827 |
| Other current assets | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $738,940 | $869,288 | $972,969 | $1,087,677 | $1,183,491 |
| Non-Current Assets | |||||
| PPE Net | 136,695 | 137,140 | 136,015 | 140,348 | 141,777 |
| Investments And Advances | 15,387 | 23,578 | 32,055 | 47,680 | 79,417 |
| Intangibles | 5,022 | 5,063 | 5,087 | 4,975 | 5,374 |
| Other Non-Current Assets | 2,253 | 2,130 | 2,023 | 1,909 | 1,954 |
| TOTAL | $159,357 | $167,911 | $175,179 | $194,911 | $228,522 |
| Total Assets | $898,297 | $1,037,198 | $1,148,148 | $1,282,589 | $1,412,014 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 28,965 | 27,257 | 26,784 | 20,241 | 14,983 |
| Accounts payable and accrued liabilities | 133,160 | 141,086 | 106,447 | 86,722 | 79,798 |
| Other current liabilities | 41,236 | 37,201 | 41,436 | 36,777 | 27,643 |
| TOTAL | $209,656 | $212,921 | $180,451 | $143,866 | $122,519 |
| Non-Current Liabilities | |||||
| Long Term Debt | 522,709 | 515,219 | 508,842 | 536,984 | 530,110 |
| Other Non-Current Liabilities | 95,229 | 129,585 | 181,391 | 146,935 | 112,519 |
| TOTAL | $617,938 | $644,804 | $690,233 | $683,919 | $642,629 |
| Total Liabilities | $827,594 | $857,725 | $870,685 | $827,786 | $765,148 |
| Shareholders' Equity | |||||
| Common Shares | 8,395 | 8,263 | 8,086 | 7,713 | 8,140 |
| Retained earnings | -2,245,429 | -2,101,416 | -1,960,215 | -1,802,516 | -1,724,720 |
| Other shareholders' equity | 1,636 | 2,701 | 3,479 | 253,666 | 255,662 |
| TOTAL | $70,703 | $179,474 | $277,463 | $454,803 | $646,866 |
| Total Liabilities And Equity | $898,297 | $1,037,199 | $1,148,148 | $1,282,589 | $1,412,014 |